Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum.

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...

Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...